Search
for
Sort by
Research 31–60 of 1000+
- Limitations of human occipital scalp hair follicle organ culture for studying the effects of minoxidil as a hair growth enhancer
- Improved cutaneous wound healing after intraperitoneal injection of alpha‐melanocyte‐stimulating hormone
- Association of alopecia areata with atopic dermatitis and chronic spontaneous urticaria
- Spray-Dried Rosuvastatin Nanoparticles for Promoting Hair Growth
- Alopecia Areata after Omalizumab Treatment for Chronic Spontaneous Urticaria
- Effects of strain and age on ear wound healing and regeneration in mice
- The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy
- Systematic review on Abrus precatorius Linn. since 1871: ethnobotanical uses, phytochemistry and pharmacological properties
- The role of 5-alpha-reductase inhibitors in active surveillance
- Developing criteria for a profession to be considered as profession of allied health in Malaysia: a qualitative study from the Malaysian perspective
- Immune-mediated Coombs negative intravascular haemolysis in systemic lupus erythematosus (SLE)
- 1451 THE ASSOCIATION BETWEEN MALE PATTERN BALDNESS AND SECOND TO FORTH FINGER RATIO WITH PROSTATE CANCER- A PROSPECTIVE COHORT STUDY
- Survivin as a Novel Biomarker in the Pathogenesis of Acne Vulgaris and Its Correlation to Insulin-Like Growth Factor-I
- Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19
- Use of a Sustained Release Preparation of Clotrimazole to Treat Dermatophytosis in a Siamang (Hylobates syndactylus)
- In vivo visualization of hair follicles by ultrasound biomicroscopy in alopecia areata and its correlation with histopathology.
- 61349 The Development of Vitiligo After Cessation of Finasteride: Is this Part of Post-Finasteride Syndrome or an Adverse Event of Finasteride?
- Patient perspectives on topical minoxidil for hair loss: a survey-based study from the University of Michigan Alopecia Clinic
- Agreement Between Patient and Physician Assessment of Eyebrow and Eyelash Hair Loss in Two Phase 3 Trials Evaluating Baricitinib in Patients with Severe Alopecia Areata
- Topical dutasteride with microneedling in treatment of male androgenetic alopecia
- Microneedling as a monotherapy in treatment of male androgenetic alopecia
- Hair loss and Hedgehog inhibitors: a class effect?
- Unraveling the impact of miRNAs on gouty arthritis: diagnostic significance and therapeutic opportunities
- Ex vivo permeation parameters and skin deposition of melatonin-loaded microemulsion for treatment of alopecia
- Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies
- 61346 Baseline Psychosocial Impact of Disease in Patients with Severe Alopecia Areata Treated with Baricitinib Recruited from the US Customer Support Program
- Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells
- Continued treatment with baricitinib results in meaningful scalp responses among scalp non‐responder patients with eyebrow/eyelash regrowth in the first year
- 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials
- 52898 Among scalp non-responder patients with eyebrow/eyelash regrowth in the first year, continued treatment with baricitinib resulted in meaningful scalp responses for patients with severe alopecia areata